Intrahospital switch of the P2Y12 inhibitors in patients with ST segment elevation myocardial infarction in ‘real-life’ clinical practice: the effect on the functional activity of thrombocytes and thrombocytopoiesis, prognostic value

MLA

L. I. Malinova, et al. “Intrahospital Switch of the P2Y12 Inhibitors in Patients with ST Segment Elevation Myocardial Infarction in ‘Real-Life’ Clinical Practice: The Effect on the Functional Activity of Thrombocytes and Thrombocytopoiesis, Prognostic Value.” Cardiovascular Therapy and Prevention, vol. 18, Sept. 2019, pp. 25–32. EBSCOhost, https://doi.org/10.15829/1728-8800-2019-4-25-32.

APA

L. I. Malinova, P. V. Dolotovskaya, N. F. Puchinyan, & V. V. Furman. (2019). Intrahospital switch of the P2Y12 inhibitors in patients with ST segment elevation myocardial infarction in ‘real-life’ clinical practice: the effect on the functional activity of thrombocytes and thrombocytopoiesis, prognostic value. Cardiovascular Therapy and Prevention, 18, 25–32. https://doi.org/10.15829/1728-8800-2019-4-25-32

Chicago

L. I. Malinova, P. V. Dolotovskaya, N. F. Puchinyan, and V. V. Furman. 2019. “Intrahospital Switch of the P2Y12 Inhibitors in Patients with ST Segment Elevation Myocardial Infarction in ‘Real-Life’ Clinical Practice: The Effect on the Functional Activity of Thrombocytes and Thrombocytopoiesis, Prognostic Value.” Cardiovascular Therapy and Prevention 18 (September): 25–32. doi:10.15829/1728-8800-2019-4-25-32.